These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24744271)

  • 1. Metabolomics approach in allergic and rheumatic diseases.
    Scrivo R; Casadei L; Valerio M; Priori R; Valesini G; Manetti C
    Curr Allergy Asthma Rep; 2014 Jun; 14(6):445. PubMed ID: 24744271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy.
    Priori R; Scrivo R; Brandt J; Valerio M; Casadei L; Valesini G; Manetti C
    Autoimmun Rev; 2013 Aug; 12(10):1022-30. PubMed ID: 23688955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of metabolomics in rheumatology.
    Gupta L; Ahmed S; Jain A; Misra R
    Int J Rheum Dis; 2018 Aug; 21(8):1468-1477. PubMed ID: 30146741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomics in rheumatic diseases: desperately seeking biomarkers.
    Guma M; Tiziani S; Firestein GS
    Nat Rev Rheumatol; 2016 May; 12(5):269-81. PubMed ID: 26935283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of metabolomics in autoimmune diseases: insight into biomarkers and pathology.
    Kang J; Zhu L; Lu J; Zhang X
    J Neuroimmunol; 2015 Feb; 279():25-32. PubMed ID: 25669996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of inflammatory-rheumatic diseases with levamisol, an immunity modulating substance].
    Trabert U; Rosenthal M; Müller W
    Schweiz Med Wochenschr; 1976 Sep; 106(39):1293-301. PubMed ID: 1087457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Semaphorins in Immunopathologies and Rheumatic Diseases.
    Garcia S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From atopic dermatitis to asthma: the atopic march.
    Spergel JM
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):99-106; quiz 107-9, 117. PubMed ID: 20674819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell phenotype in allergic asthma and atopic dermatitis.
    Wohlfahrt JG; Kunzmann S; Menz G; Kneist W; Akdis CA; Blaser K; Schmidt-Weber CB
    Int Arch Allergy Immunol; 2003 Aug; 131(4):272-82. PubMed ID: 12915770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
    Saegusa J; Kawano S; Morinobu A
    Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the atopic march: Results from the Canadian Healthy Infant Longitudinal Development Study.
    Tran MM; Lefebvre DL; Dharma C; Dai D; Lou WYW; Subbarao P; Becker AB; Mandhane PJ; Turvey SE; Sears MR;
    J Allergy Clin Immunol; 2018 Feb; 141(2):601-607.e8. PubMed ID: 29153857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixing omics: combining genetics and metabolomics to study rheumatic diseases.
    Menni C; Zierer J; Valdes AM; Spector TD
    Nat Rev Rheumatol; 2017 Mar; 13(3):174-181. PubMed ID: 28148918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptors in allergic diseases.
    Castan L; Magnan A; Bouchaud G
    Allergy; 2017 May; 72(5):682-690. PubMed ID: 27864967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections and atopy: an exploratory study for a meta-analysis of the "hygiene hypothesis".
    Randi G; Altieri A; Chatenoud L; Chiaffarino F; La Vecchia C
    Rev Epidemiol Sante Publique; 2004 Dec; 52(6):565-74. PubMed ID: 15741918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palindromic rheumatism: an allergic manifestation?
    Margolis J; Margolis LS
    J Am Geriatr Soc; 1977 Apr; 25(4):189-91. PubMed ID: 300382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseases.
    Smoleńska Ż; Zdrojewski Z
    Reumatologia; 2015; 53(3):152-6. PubMed ID: 27407242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-mediated immune regulation in rheumatic diseases.
    Lam IKY; Chow JX; Lau CS; Chan VSF
    Cancer Lett; 2018 Sep; 431():201-212. PubMed ID: 29859876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production.
    Koning H; Neijens HJ; Baert MR; Oranje AP; Savelkoul HF
    Cytokine; 1997 Jun; 9(6):416-26. PubMed ID: 9199876
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.